Home›Companies›Biotech & Pharma›Orbit Genomics

Orbit Genomics, Inc.

Updated Oct 29, 2026·Latest SEC filing Jul 28, 2025·Suggest an edit

About Orbit Genomics

Orbit Genomics is a private company based in Boulder, Colorado. It has reported $780,000 raised in one offering on Form D since March 2025. Its chief executive is Elizabeth (Dede) Willis.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 29, 2024Mar 18, 2025amended Jul 28, 2025$780,000of $2.0M target15$52,000Debt, OptionsRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Orbit Genomics's Form D filed Jul 28, 2025.

OM
Oerum Mikael
Director
HG
Harold (Skip) Garner
Executive officer and director
EW
Elizabeth (Dede) Willis
President & CEO, director
JS
Julie Silber
Director

Sources

  1. SECOrbit Genomics, Inc. Form D, filed Mar 18, 2025
  2. SECOrbit Genomics, Inc. filing history